Know Cancer

or
forgot password

Assessment of Tumor Resistance and Stem Cells in Prostate Cancer


N/A
18 Years
N/A
Not Enrolling
Male
Prostate Cancer

Thank you

Trial Information

Assessment of Tumor Resistance and Stem Cells in Prostate Cancer


OBJECTIVES:

- Collect prostate tissue and other biological specimens for assessment of biological
markers that may relate to tumor progression and resistance and for future isolation of
stem cells and biologic markers.

Biological samples, including serum and mononuclear cells and tumor tissue, are collected
before and during surgery. Specimens are frozen and stored indefinitely.

Inclusion Criteria


DISEASE CHARACTERISTICS:

- Undergoing routine prostatectomy or transurethral resection of the prostate (TURP)

PATIENT CHARACTERISTICS:

5.1.1 Patient is undergoing routine prostatectomy or TURP.

5.1.2 Patient is ≥ 18 years old.

5.1.3 Patient must give informed consent.

PRIOR CONCURRENT THERAPY:

- See Disease Characteristics

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

Collection and freezing of tumor samples

Outcome Time Frame:

5 years

Safety Issue:

No

Principal Investigator

Isaac Kim, MD, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Cancer Institute of New Jersey

Authority:

United States: Institutional Review Board

Study ID:

CDR0000648129

NCT ID:

NCT00991315

Start Date:

December 2008

Completion Date:

December 2008

Related Keywords:

  • Prostate Cancer
  • prostate cancer
  • Prostatic Neoplasms

Name

Location

Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical SchoolNew Brunswick, New Jersey  08903